Clinical Trial Update: Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis [NA]

View source ↗

Summary

This clinical trial update describes safety, tolerability, and performance of the NucleoCapture extracorporeal apheresis device in reducing circulating cfDNA an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome
• Pancreatitis

Drugs mentioned

• NucleoCapture Extracorporeal Therapeutic Apheresis Device

Snippet

Sponsor: Liverpool University Hospitals NHS Foundation Trust | Conditions: Acute Pancreatitis, Organ Failure, Multiple | NA | Status: NOT_YET_RECRUITING